Your browser doesn't support javascript.
loading
Phenytoin for neuroprotection - Authors' reply.
Kapoor, Raju; Raftopoulos, Rhian; Altmann, Daniel R; Miller, David H; Hickman, Simon J.
Affiliation
  • Kapoor R; National Hospital for Neurology and Neurosurgery, London, UK; University College London Institute of Neurology, London, WC1N 3BG, UK; Queen Square Multiple Sclerosis Centre, London, UK. Electronic address: r.kapoor@nhs.net.
  • Raftopoulos R; National Hospital for Neurology and Neurosurgery, London, UK; University College London Institute of Neurology, London, WC1N 3BG, UK; Queen Square Multiple Sclerosis Centre, London, UK.
  • Altmann DR; Queen Square Multiple Sclerosis Centre, London, UK; Medical Statistics Department, London School of Hygiene and Tropical Medicine, London, UK.
  • Miller DH; National Hospital for Neurology and Neurosurgery, London, UK; University College London Institute of Neurology, London, WC1N 3BG, UK; Queen Square Multiple Sclerosis Centre, London, UK.
  • Hickman SJ; Royal Hallamshire Hospital, Sheffield, UK.
Lancet Neurol ; 15(9): 902-903, 2016 08.
Article in En | MEDLINE | ID: mdl-27478948
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenytoin / Neuroprotection Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2016 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenytoin / Neuroprotection Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2016 Document type: Article Country of publication: United kingdom